# Positron Emission Tomography (PET) Contrast Agent Kinetics and Safety: [18F]-Fluoromannitol

> **NCT07110519** · EARLY_PHASE1 · RECRUITING · sponsor: **St. Jude Children's Research Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [18F]-fluoromannitol

## Key facts

- **NCT ID:** NCT07110519
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-17
- **Primary completion:** 2026-05
- **Final completion:** 2027-05
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07110519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07110519, "Positron Emission Tomography (PET) Contrast Agent Kinetics and Safety: [18F]-Fluoromannitol". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07110519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*